Cargando…
Modeling Endometrial Cancer: Past, Present, and Future
Endometrial cancer is the most common type of cancer of the female reproductive tract. Although prognosis is generally good for patients with low-grade and early-stage diseases, the outcomes for high-grade and metastatic/recurrent cases remain poor, since traditional chemotherapy regimens based on p...
Autores principales: | Van Nyen, Tom, Moiola, Cristian P., Colas, Eva, Annibali, Daniela, Amant, Frédéric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121384/ https://www.ncbi.nlm.nih.gov/pubmed/30096949 http://dx.doi.org/10.3390/ijms19082348 |
Ejemplares similares
-
Patient-Derived Xenograft Models for Endometrial Cancer Research
por: Moiola, Cristian P., et al.
Publicado: (2018) -
Endometrial Cancer Molecular Characterization: The Key to Identifying High-Risk Patients and Defining Guidelines for Clinical Decision-Making?
por: Baiden-Amissah, Regina Esi Mensimah, et al.
Publicado: (2021) -
Past, present, and future of hormonal therapy in recurrent endometrial cancer
por: Carlson, Matthew J, et al.
Publicado: (2014) -
The Effects of Cannabidiol and Prognostic Role of TRPV2 in Human Endometrial Cancer
por: Marinelli, Oliviero, et al.
Publicado: (2020) -
Small-Molecule Inhibitors (SMIs) as an Effective Therapeutic Strategy for Endometrial Cancer
por: Megino-Luque, Cristina, et al.
Publicado: (2020)